tiprankstipranks
BridgeBio Oncology Therapeutics (BBOT)
NASDAQ:BBOT
US Market
BBOT
BridgeBio Oncology Therapeutics
RESEARCH TOOLSreports
Want to see BBOT full AI Analyst Report?

BridgeBio Oncology Therapeutics (BBOT) Ratios

70 Followers

BridgeBio Oncology Therapeutics Ratios

BBOT's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, BBOT's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.69 12.14 10.40 0.00 0.00
Quick Ratio
 4.69 12.14 10.40 0.00 0.00
Cash Ratio
 1.05 10.66 9.05 0.00 0.00
Solvency Ratio
 -3.39 -3.58 -12.98 -162.96 -0.02
Operating Cash Flow Ratio
 -3.74 -3.25 -4.07 0.00 0.00
Short-Term Operating Cash Flow Coverage
 -348.63 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 188.78M$ 388.18M$ -3.76M$ -396.46K$ -166.46K
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 0.00 0.21 0.30
Debt-to-Equity Ratio
 <0.01 <0.01 0.00 -1.10 -1.97
Debt-to-Capital Ratio
 <0.01 <0.01 0.00 10.74 2.03
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 0.00 0.00 0.00
Financial Leverage Ratio
 1.17 1.09 1.03 -5.24 -6.61
Debt Service Coverage Ratio
 -351.37 0.00 0.00 -922.73 -0.08
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 <0.01 <0.01 0.00 <0.01 <0.01
Interest Debt Per Share
 31.40 0.09 0.00 <0.01 <0.01
Net Debt to EBITDA
 0.26 2.55 0.02 >-0.01 -12.25
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
91.54%91.92%91.85%99.89%100.00%
Return on Assets (ROA)
-48.34%-29.90%-38.20%-19435.32%-2.43%
Return on Equity (ROE)
-46.90%-32.61%-39.36%101777.60%16.09%
Return on Capital Employed (ROCE)
-61.20%-35.28%-41.63%101890.86%16.09%
Return on Invested Capital (ROIC)
-61.10%-35.23%-41.63%-992506.90%-16.58%
Return on Tangible Assets
-48.34%-29.90%-38.20%-19435.32%-2.43%
Earnings Yield
-41211.77%-34.38%-42.52%-30.99%>-0.01%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 0.03 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 -13.20K 0.00 0.00 0.00 0.00
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 13.20K 0.00 0.00 0.00 0.00
Operating Cycle
 0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -2.41K -3.66 -0.05 0.00 0.00
Free Cash Flow Per Share
 -2.42K -3.68 -0.05 0.00 0.00
CapEx Per Share
 8.46 0.02 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.01 1.00 0.00 0.00
Dividend Paid and CapEx Coverage Ratio
 -285.29 -187.94 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
 -285.29 -187.94 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 -76.83 -41.18 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-43.83%-29.36%-0.44%0.00%0.00%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 >-0.01 -2.91 -2.35 -3.23 -59.30K
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 <0.01 0.95 0.93 -3.28K -9.54K
Price-to-Free Cash Flow (P/FCF) Ratio
 -2.28 -3.41 -228.69 0.00 0.00
Price-to-Operating Cash Flow Ratio
 >-0.01 -3.42 -228.69 0.00 0.00
Price-to-Earnings Growth (PEG) Ratio
 <0.01 0.03 0.02 0.00 593.02
Price-to-Fair Value
 <0.01 0.95 0.93 -3.28K -9.54K
Enterprise Value Multiple
 -2.01 -0.13 -2.14 -3.23 -59.31K
Enterprise Value
 390.64M 19.01M 172.98M 208.81M 208.79M
EV to EBITDA
 -2.01 -0.13 -2.14 -3.23 -59.31K
EV to Sales
 0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 -2.02 -0.17 -226.47 0.00 0.00
EV to Operating Cash Flow
 -2.02 -0.17 -226.47 0.00 0.00
Tangible Book Value Per Share
 4.04K 13.20 11.34 >-0.01 >-0.01
Shareholders’ Equity Per Share
 4.04K 13.20 11.34 >-0.01 >-0.01
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.00 0.00 0.00 0.00 0.00
Net Income Per Share
 -2.27K -4.30 -4.46 -3.16 >-0.01
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.93 0.92 0.92 1.00 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.06 0.85 -0.10 0.00 0.00
Currency in USD